Related Experiment Video
Updated: Sep 27, 2025
02:28
Author Spotlight: Self-Assessment Protocol for Predicting Psoriatic Arthritis in Psoriasis Patients
Published on: March 1, 2024
521
The Detroit Keloid Scale: A Validated Tool for Rating Keloids
Alexis B Lyons1, David M Ozog1, Henry W Lim1
1Department of Dermatology, Henry Ford Hospital, Detroit, Michigan, USA.
Facial Plastic Surgery & Aesthetic Medicine
|April 8, 2022
Summary
A new keloid assessment tool, the Detroit Keloid Scale (DKS), demonstrates substantial reliability and validity. This keloid scale offers a standardized method for evaluating treatment effectiveness.
Area of Science:
- Dermatology
- Medical Assessment Tools
- Scarring Research
Background:
- Current keloid treatment comparisons are hindered by a lack of standardized assessment systems.
- A reliable classification system is needed to accurately evaluate treatment responses.
Purpose of the Study:
- To develop and validate the Detroit Keloid Scale (DKS) as a standardized keloid assessment method.
- To establish a reliable tool for comparing keloid treatment outcomes.
Main Methods:
- The Detroit Keloid Scale (DKS) was developed through physician polling (n=47).
- DKS was validated in 52 patients against established scales: Vancouver Scar Scale (VSS), Patient and Observer Scar Assessment Scale (POSAS), and Dermatology Life Quality Index (DLQI).
Main Results:
- DKS exhibited substantial inter-rater reliability (ICC=0.80), outperforming VSS (ICC=0.60) and observer POSAS (ICC=0.47).
- DKS showed moderate to substantial correlations with VSS, POSAS, and DLQI, confirming its validity.
- Patient-reported DKS also correlated significantly with patient-reported POSAS and DLQI.
Conclusions:
- The Detroit Keloid Scale (DKS) is a validated, keloid-specific outcome measure.
- DKS provides a reliable tool for comparing the efficacy of different keloid treatments.
